Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
10 Leser
Artikel bewerten:
(0)

UK Hemostasis Diagnostics Market 2015-2019: Supplier Shares, Country Forecasts, Innovative Technologies & Competitive Strategies

DUBLIN, Sept. 10, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/ms7732/2015_uk) has announced the addition of the "2015 UK Hemostasis Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering.

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market during the next five years.

The report explores business and technological trends in the UK coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.


Market Segmentation Analysis

Comprehensive market segmentation analysis, including:

- Hospitals
- Commercial/Private Laboratories
- Test volume forecasts for over 40 major procedures by market segment.

Current and Emerging Products

- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.

Companies Mentioned

- Diagnostica Stago
- Helena
- IL
- Siemens
- Sysmex

For more information visit http://www.researchandmarkets.com/research/ms7732/2015_uk

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.